A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.

• 主要な著者: David Safronetz (著者), Chad Mire (著者), Kyle Rosenke (著者), Friederike Feldmann (著者), Elaine Haddock (著者), Thomas Geisbert (著者), Heinz Feldmann (著者)
• フォーマット: 図書
• 出版事項: Public Library of Science (PLoS), 2015-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Lassa virus (LASV) is endemic in several West African countries and is the etiological agent of Lassa fever. Despite the high annual incidence and significant morbidity and mortality rates, currently there are no approved vaccines to prevent infection or disease in humans. Genetically, LASV demonstr...